Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
332 studies found for:    Alemtuzumab
Show Display Options
Rank Status Study
1 Completed CHO(E)P-14 Followed by Alemtuzumab Consolidation in Peripheral T Cell Lymphoma
Condition: Peripheral T-Cell Lymphoma
Intervention: Drug: Alemtuzumab
2 Withdrawn Alemtuzumab and Rituximab in Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: Alemtuzumab and Rituximab
3 Completed
Has Results
Safety and Efficacy of Alemtuzumab in Pediatric Intestinal Transplantation
Conditions: Evidence of Liver Transplantation;   Rejection;   ALEMTUZUMAB
Intervention: Drug: Alemtuzumab
4 Unknown  Alemtuzumab for ANCA Associated Refractory Vasculitis
Conditions: Vasculitis;   Microscopic Polyangiitis;   Granulomatosis With Polyangiitis;   Wegener's
Intervention: Drug: Alemtuzumab
5 Active, not recruiting A Phase II Trial of Alemtuzumab and Rituximab in Patients With Previously Untreated CLL
Condition: Leukemia
Interventions: Biological: Alemtuzumab;   Biological: Rituximab
6 Not yet recruiting Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis
Condition: Multiple Sclerosis (MS)
Intervention: Drug: Alemtuzumab
7 Active, not recruiting Study of Alemtuzumab in Treatment Refractory MS Subjects/Alemtuzumab Naive & Alemtuzumab Experienced Subjects
Condition: Multiple Sclerosis
Interventions: Drug: Alemtuzumab;   Drug: Alemtuzumab immunotherapy
8 Completed
Has Results
Combination of Alemtuzumab and Rituximab at Low-doses in Refractory Chronic Graft-Versus-Host Disease
Condition: Graft vs Host Disease
Intervention: Drug: Alemtuzumab and rituximab
9 Active, not recruiting Alemtuzumab on Surrogate Markers of Disease Activity and Repair Using Advanced MRI Measures in Subjects With Relapsing Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Alemtuzumab
10 Terminated
Has Results
Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)
Condition: Leukemia
Intervention: Drug: Alemtuzumab
11 Not yet recruiting Cyclophosphamide and Alemtuzumab In Lymphoma
Conditions: Non Hodgkin Lymphoma;   High-grade B-cell Lymphoma;   CD52 Positive Non-Hodgkin Lymphoma;   DLBCL or High-grade B-cell Lymphoma NOS
Interventions: Drug: Cyclophosphamide;   Drug: Alemtuzumab
12 Active, not recruiting Advanced MRI Measures of Repair in Alemtuzumab Treated Patients
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Drug: MabCampath-1h
13 Completed Alemtuzumab (CAMPATH 1H) Associated to G-CSF in Adult Patients With Refractory Acute Lymphocytic Leukemia
Condition: Acute Lymphocytic Leukemia
Intervention: Drug: Alemtuzumab (CAMPATH 1H) associated to G-CSF
14 Recruiting Keratinocyte Growth Factor to Prevent Autoimmunity After Alemtuzumab Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Palifermin;   Drug: Alemtuzumab
15 Terminated The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCL
Condition: Peripheral T-Cell Lymphoma
Intervention: Drug: Alemtuzumab
16 Completed Weekly Subcutaneous Alemtuzumab and Rituximab for Relapsed CLL
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Rituximab;   Drug: Alemtuzumab
17 Unknown  Evaluating Alemtuzumab as a Treatment in Stabilizing Neurocognitive Function In Relapsing Remitting Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Intervention: Drug: Alemtuzumab
18 Terminated The Efficacy and Safety of Alemtuzumab in Auotoimmune Cytopenias
Condition: Autoimmune Cytopenias
Intervention: Drug: Alemtuzumab
19 Completed
Has Results
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Biological: alemtuzumab
20 Completed Infections Associated With the Use of Alemtuzumab
Condition: Patients Treated With Alemtuzumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.